Dudediligence.

PMGC Holdings Inc

ELABNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$285,948Sep ’25$304,136Dec ’25$681,994Mar ’26$1.3MJun ’26
Net income, by quarter
−$1.5MSep ’24−$1.9MDec ’24−$1.6MMar ’25−$562,355Jun ’25−$2.6MSep ’25−$3.0MDec ’25−$5.0MMar ’26−$2.9MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$766,277$1.7Mnone on file$590,084
Gross profitnone on file$447,309$1.1Mnone on file$185,314
Net incomenone on file−$1.8M−$4.3M−$6.2M−$7.7M
Operating cash flownone on file−$1.6M−$4.6M−$5.5M−$5.9M
Free cash flownone on file−$1.6M−$4.6M−$5.5M−$6.4M
Cash$411,858$1.2M$3.3M$4.0M$5.4M
Shares outstandingnone on file9.6M12.4K5.2K80.7K